Sekhmet Pharmaventures acquires a controlling stake in Optimus Group

27 Sep 2022 , 07:09 AM

Through the API platform Sekhmet Pharmaventures, PAG, a renowned international investment firm, along with consortium partners CX Partners and Samara Capital, purchased a controlling interest in the Hyderabad-based pharmaceutical company Optimus Group.

Optimus, a manufacturer of pharmaceutical goods with vertical integration that includes advanced intermediates, active pharmaceutical ingredients (APIs), and finished medications, was established in 2004. Presently, it exports to 40 nations more than 100 different items.

The consortium, which wants to create a best-in-class centre for discovering and producing bulk medicinal ingredients, entered into the agreement after purchasing Anjan Drugs in 2020.

India is a particularly appealing market in PAG’s eyes. With this deal, PAG will have invested more than $700 million in private equity across a variety of sectors in India over the past two years.

For feedback and suggestions, write to us at [e-mail]